These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 35033824
1. Novel PHD2/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury. Wei H, Gou W, Gao J, Ning H, Song Y, Li D, Qin Y, Hou W, Li Y. Eur J Med Chem; 2022 Feb 15; 230():114115. PubMed ID: 35033824 [Abstract] [Full Text] [Related]
3. Histone deacetylase expression following cisplatin-induced acute kidney injury in male and female mice. Nguyen H, Gales A, Monteiro-Pai S, Oliver AS, Harris N, Montgomery AD, Franzén S, Kasztan M, Hyndman KA. Am J Physiol Renal Physiol; 2024 Oct 01; 327(4):F623-F636. PubMed ID: 39116350 [Abstract] [Full Text] [Related]
4. 2-Methylquinazoline derivative 23BB as a highly selective histone deacetylase 6 inhibitor alleviated cisplatin-induced acute kidney injury. Hao Y, Guo F, Huang Z, Feng Y, Xia Z, Liu J, Li L, Huang R, Lin L, Ma L, Fu P. Biosci Rep; 2020 Jan 31; 40(1):. PubMed ID: 31894849 [Abstract] [Full Text] [Related]
5. Ursodeoxycholic acid protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction through acting on ALDH1L2. Yang Y, Liu S, Gao H, Wang P, Zhang Y, Zhang A, Jia Z, Huang S. Free Radic Biol Med; 2020 May 20; 152():821-837. PubMed ID: 32004633 [Abstract] [Full Text] [Related]
6. Asiatic acid protects against cisplatin-induced acute kidney injury via anti-apoptosis and anti-inflammation. Yang C, Guo Y, Huang TS, Zhao J, Huang XJ, Tang HX, An N, Pan Q, Xu YZ, Liu HF. Biomed Pharmacother; 2018 Nov 20; 107():1354-1362. PubMed ID: 30257350 [Abstract] [Full Text] [Related]
7. 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation. Wu WF, Wang JN, Li Z, Wei B, Jin J, Gao L, Li HD, Li J, Chen HY, Meng XM. Phytomedicine; 2020 Apr 20; 69():153202. PubMed ID: 32169782 [Abstract] [Full Text] [Related]
8. Histone deacetylase–mediated silencing of AMWAP expression contributes to cisplatin nephrotoxicity. Ranganathan P, Hamad R, Mohamed R, Jayakumar C, Muthusamy T, Ramesh G. Kidney Int; 2016 Feb 20; 89(2):317-26. PubMed ID: 26509586 [Abstract] [Full Text] [Related]
9. Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation. Yang Q, Zang HM, Xing T, Zhang SF, Li C, Zhang Y, Dong YH, Hu XW, Yu JT, Wen JG, Jin J, Li J, Zhao R, Ma TT, Meng XM. Phytomedicine; 2021 May 20; 85():153541. PubMed ID: 33773190 [Abstract] [Full Text] [Related]
12. Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury. Tang J, Shi Y, Liu N, Xu L, Zang X, Li P, Zhang J, Zheng X, Qiu A, Zhuang S. Clin Sci (Lond); 2018 Feb 14; 132(3):339-359. PubMed ID: 29358506 [Abstract] [Full Text] [Related]
13. Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy. Liu XQ, Jin J, Li Z, Jiang L, Dong YH, Cai YT, Wu MF, Wang JN, Ma TT, Wen JG, Liu MM, Li J, Wu YG, Meng XM. Biochem Pharmacol; 2020 Oct 14; 180():114132. PubMed ID: 32622666 [Abstract] [Full Text] [Related]
14. Prolyl hydroxylase 2 (PHD2) inhibition protects human renal epithelial cells and mice kidney from hypoxia injury. Fang Y, Zhang H, Zhong Y, Ding X. Oncotarget; 2016 Aug 23; 7(34):54317-54328. PubMed ID: 27527871 [Abstract] [Full Text] [Related]
15. PSTPIP2 inhibits cisplatin-induced acute kidney injury by suppressing apoptosis of renal tubular epithelial cells. Zhu H, Jiang W, Zhao H, He C, Tang X, Xu S, Xu C, Feng R, Li J, Ma T, Huang C. Cell Death Dis; 2020 Dec 12; 11(12):1057. PubMed ID: 33311489 [Abstract] [Full Text] [Related]
16. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning. Jiao X, Xu X, Fang Y, Zhang H, Liang M, Teng J, Ding X. Nephrology (Carlton); 2017 May 12; 22(5):366-373. PubMed ID: 27030384 [Abstract] [Full Text] [Related]
17. Repurposing AZD5438 and Dabrafenib for Cisplatin-Induced AKI. Pushpan CK, Kresock DF, Ingersoll MA, Lutze RD, Keirns DL, Hunter WJ, Bashir K, Teitz T. J Am Soc Nephrol; 2024 Jan 01; 35(1):22-40. PubMed ID: 37962623 [Abstract] [Full Text] [Related]
18. Mitochondria targeted peptide SS-31 prevent on cisplatin-induced acute kidney injury via regulating mitochondrial ROS-NLRP3 pathway. Yang SK, Han YC, He JR, Yang M, Zhang W, Zhan M, Li AM, Li L, Na-Song, Liu YT, Wu XQ, Zhang Q, Wang JW, Zhang H. Biomed Pharmacother; 2020 Oct 01; 130():110521. PubMed ID: 32717631 [Abstract] [Full Text] [Related]
19. Dipeptidyl peptidase-4 inhibitor teneligliptin accelerates recovery from cisplatin-induced acute kidney injury by attenuating inflammation and promoting tubular regeneration. Iwakura T, Zhao Z, Marschner JA, Devarapu SK, Yasuda H, Anders HJ. Nephrol Dial Transplant; 2019 Oct 01; 34(10):1669-1680. PubMed ID: 30624740 [Abstract] [Full Text] [Related]
20. Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells. Liu J, Livingston MJ, Dong G, Tang C, Su Y, Wu G, Yin XM, Dong Z. Cell Death Dis; 2018 Feb 23; 9(3):322. PubMed ID: 29476062 [Abstract] [Full Text] [Related] Page: [Next] [New Search]